LTC Properties Inc vs GeneDx Holdings Corp — how do they compare? LTC Properties Inc trades at $38.12 (market cap $2.05B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: GeneDx Holdings Corp is the larger of the two by market cap, and LTC Properties Inc pays a 5.98% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| LTC | WGS | |
|---|---|---|
Market Cap | $2.05B | $2.44B |
Sector | Real Estate | Technology |
52-Week High | $42.81 | $167.51 |
52-Week Low | $33.98 | $34.51 |
Enterprise Value | $2.79B | $2.48B |
Dividend Yield | 5.98% | — |
Signals from Pluang's Aura AI — not financial advice
LTC Properties (LTC) trades at $38.69, down 1.85% over 24 hours, with technical indicators showing a bearish trend despite oversold RSI readings. The company reported Q2 2026 earnings that beat expectations, with EPS of $0.56 versus $0.48 expected, and continues aggressive SHOP portfolio expansion, with recent acquisitions totaling over $285 million year-to-date. Revenue grew to $262.85 million in 2025, and net income margin remains strong at 38.93%, though recent quarters show mixed earnings performance.
LTC presents a mixed outlook; strong fundamentals and dividend yield near 5.9% appeal to income investors, but bearish technicals and elevated debt levels pose risks. Analyst consensus is cautious with 59% hold ratings, reflecting concerns over execution amid rapid portfolio growth. Key catalysts include SHOP acquisition success and demographic tailwinds, while risks involve interest rate sensitivity and integration challenges.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Trailing returns across standard periods
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →